Global Biobanking Market

Global Biobanking Market Overview

• The Global Biobanking Market Size was worth around USD 78.33 Billion in 2023 and is Predicted to Grow to around USD 170.81 Billion by 2033 with a compound annual growth rate (CAGR) of 8.11% between 2023 and 2033.
• The biobanking industry is gaining traction due to advanced technologies, automation, and data analytics.
• The global biobanking market is driven by rising chronic diseases and pharmaceutical investments. Key drivers include genomic research, cord blood stem cell conservation, drug development, and regenerative medicine research.
• The Growing Number of Biobanks and Human Bio-Samples contribute to the demand for biobanking equipment.

Major vendors in the Global Biobanking Market 

Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Brooks Life Sciences, TTP Labtech, VWR International, LLC., Promega Corporation, Worthington Industries, BD, Merck KGaA, Biokryo GmbH, Cell&Co BioServices, RUCDR Infinite Biologics, Modul-Bio, and Others.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Decision Advisors has segmented the biobanking market based on the below-mentioned segments:

Global Biobanking Market, By Product

• Equipment
• Consumables
• Laboratory Information Systems

Global Biobanking Market, By Service

• Biobanking and Repository
• Validation/Qualification
• Lab Processing
• Cold Chain Logistic
• Others

Global Biobanking Market, By Biospecimen Type

• Human Tissues
• Stem Cells
• Organs
• Others

Global Biobanking Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa